Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01357291 · ClinicalTrials.gov registry record · NA
Evaluating New Mexico's Recidivism Reduction Program
A NA study, sponsored by Pepperdine University.
- Completed
- Registry status
- NA
- Development phase
- 159
- Enrollment target
NCT01357291: Completed NA study, sponsored by Pepperdine University.
NCT01357291 is a NA study that has completed, run by Pepperdine University. The registered enrollment target is 159 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01357291, a NA study, has completed, sponsored by Pepperdine University.
- COMPLETED
- Registry status
- NA
- Development phase
- 159 participants
- Enrollment target
Study Summary
A a multi-site trial to measure the efficacy of the Recidivism Reduction Program, a prison based, twenty-one module reentry program operated by the New Mexico Department of Corrections.
Primary Outcome
Percentage of subjects in each condition who are revoked from parole and returned to prison during the 12 months following their initial release.
Interventions
- BEHAVIORAL Recidivism Reduction Program
- BEHAVIORAL Business-as-usual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-05 |
| Phase | NA |
What the finished NCT01357291 record still lists
NCT01357291 is an interventional study that assigns participants to a tested intervention. The registered 159 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Recidivism Reduction Program is the first listed.
NCT01357291 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01357291 about?
NCT01357291 is a clinical study titled "Evaluating New Mexico's Recidivism Reduction Program". A a multi-site trial to measure the efficacy of the Recidivism Reduction Program, a prison based, twenty-one module reentry program operated by the New Mexico Department of Corrections.
What is the current status of trial NCT01357291?
This trial is currently completed. It is a NA study. The enrollment target is 159 participants. The study started on 2011-03. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01357291?
The interventions under investigation include: Recidivism Reduction Program (BEHAVIORAL), Business-as-usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT01357291?
This trial is sponsored by Pepperdine University, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01357291's enrollment target sits among peer trials
159 654th of 2000 higher than 1,347 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05267626 · 159 participants · Phase 1
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- NCT06321575 · 159 participants · NA
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
- NCT06729151 · 159 participants
Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome
- NCT07023731 · 159 participants · Phase 1
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia